1887

Abstract

Purpose. Methicillin-resistant Staphylococcus aureus (MRSA) colonizes the skin of hospitalized patients and is associated with high morbidity and mortality. To prevent colonization and infection by S. aureus, better disinfection practices are required. Therefore, we evaluated the effect of chlorhexidine whole-body washing on hospital-acquired S. aureus infections among intensive care unit (ICU) patients in a tertiary hospital in Mexico.

Methodology. The study was conducted over 18 months to evaluate the effect of 2 % chlorhexidine gluconate (CXG) whole-body washing of ICU adult patients on chlorhexidine and antibiotic resistance, biofilm production and clonal distribution of S. aureus in a tertiary care hospital. Minimum inhibitory concentrations for CXG, antibiotic susceptibility and biofilm production by S. aureus isolates were determined. Pulsed-field gel electrophoresis, multilocus sequence typing (MLST) and PCR for Panton–Valentine leucocidin (PVL) were used for molecular typing of MRSA isolates.

Results/Key findings. We included 158 isolates. A reduction in antibiotic resistance in the study period was observed for clindamycin, levofloxacin, norfloxacin, oxacillin and trimethoprim/sulfamethoxazole. None of the isolates showed reduced susceptibility to CXG. Most of the isolates were non-biofilm producers (147/158). The most commonly identified clone was a descendant of the ST5-MRSA-II (New York/Japan) clone. This clone decreased during the intervention period and reappeared markedly in the post-intervention period. During the post-intervention period, two isolates were related with the clone ST8-MRSA-IV (also known as USA300).

Conclusion. Our findings suggest that the CXG bathing favored the reduction of healthcare-associated MRSA isolates and a temporary reduction of the predominant ST5-MRSA-II (New York/Japan) clone.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000487
2017-06-08
2019-10-14
Loading full text...

Full text loading...

/deliver/fulltext/jmm/66/6/721.html?itemId=/content/journal/jmm/10.1099/jmm.0.000487&mimeType=html&fmt=ahah

References

  1. Cha JO, Yoo JI, Yoo JS, Chung HS, Park SH et al. Investigation of biofilm formation and its association with the molecular and clinical characteristics of Methicillin-resistant Staphylococcus aureus. Osong Public Health Res Perspect 2013;4:225–232 [CrossRef][PubMed]
    [Google Scholar]
  2. Dauwalder O, Lina G, Durand G, Bes M, Meugnier H et al. Epidemiology of invasive methicillin-resistant Staphylococcus aureus clones collected in France in 2006 and 2007. J Clin Microbiol 2008;46:3454–3458 [CrossRef][PubMed]
    [Google Scholar]
  3. Bouchiat C, Moreau K, Devillard S, Rasigade JP, Mosnier A et al. Staphylococcus aureus infective endocarditis versus bacteremia strains: subtle genetic differences at stake. Infect Genet Evol 2015;36:524–530 [CrossRef][PubMed]
    [Google Scholar]
  4. Del Giudice P, Blanc V, Durupt F, Bes M, Martinez JP et al. Emergence of two populations of methicillin-resistant Staphylococcus aureus with distinct epidemiological, clinical and biological features, isolated from patients with community-acquired skin infections. Br J Dermatol 2006;154:118–124 [CrossRef][PubMed]
    [Google Scholar]
  5. Rasigade JP, Vandenesch F. Staphylococcus aureus: a pathogen with still unresolved issues. Infect Genet Evol 2014;21:510–514 [CrossRef][PubMed]
    [Google Scholar]
  6. Enright MC, Robinson DA, Randle G, Feil EJ, Grundmann H et al. The evolutionary history of methicillin-resistant Staphylococcus aureus (MRSA). Proc Natl Acad Sci USA 2002;99:7687–7692 [CrossRef][PubMed]
    [Google Scholar]
  7. Enright MC. The evolution of a resistant pathogenthe case of MRSA. Curr Opin Pharmacol 2003;3:474–479 [CrossRef][PubMed]
    [Google Scholar]
  8. Oliveira DC, Tomasz A, de Lencastre H. Secrets of success of a human pathogen: molecular evolution of pandemic clones of meticillin-resistant Staphylococcus aureus. Lancet Infect Dis 2002;2:180–189 [CrossRef][PubMed]
    [Google Scholar]
  9. Rodríguez-Noriega E, Seas C, Guzmán-Blanco M, Mejía C, Alvarez C et al. Evolution of methicillin-resistant Staphylococcus aureus clones in Latin America. Int J Infect Dis 2010;14:e560e566 [CrossRef][PubMed]
    [Google Scholar]
  10. Velazquez-Meza ME, Hernández-Salgado M, Contreras-Cordero JF, Pérez-Cortes P, Villarreal-Treviño L. Surveillance of methicillin-resistant Staphylococcus aureus causing nosocomial infections in five medical centers of Monterrey, Nuevo León, México from 2005-2009. Arch Med Res 2013;44:570–574 [CrossRef][PubMed]
    [Google Scholar]
  11. Soto-Hernandez JL. Chlorhexidine bathing and infections in critically ill patients. JAMA 2015;313:1863 [CrossRef]
    [Google Scholar]
  12. Climo MW, Yokoe DS, Warren DK, Perl TM, Bolon M et al. Effect of daily chlorhexidine bathing on hospital-acquired infection. N Engl J Med 2013;368:533–542 [CrossRef][PubMed]
    [Google Scholar]
  13. Gidengil CA, Gay C, Huang SS, Platt R, Yokoe D et al. Cost-effectiveness of strategies to prevent methicillin-resistant Staphylococcus aureus transmission and infection in an intensive care unit. Infect Control Hosp Epidemiol 2015;36:17–27 [CrossRef][PubMed]
    [Google Scholar]
  14. Evans HL, Dellit TH, Chan J, Nathens AB, Maier RV et al. Effect of chlorhexidine whole-body bathing on hospital-acquired infections among trauma patients. Arch Surg 2010;145:240–246 [CrossRef][PubMed]
    [Google Scholar]
  15. Petlin A, Schallom M, Prentice D, Sona C, Mantia P et al. Chlorhexidine gluconate bathing to reduce methicillin-resistant Staphylococcus aureus acquisition. Crit Care Nurse 2014;34:17–24 [CrossRef][PubMed]
    [Google Scholar]
  16. Murray PR, Baron EJ, Jorgensen JH, Landry ML, Pfaller MA. (editors) Manual of Clinical Microbiology, 9th ed. Washington, DC: ASM press; 2007
    [Google Scholar]
  17. CLSI M100-S26: Performance Standards for Antimicrobial Susceptibility Testing, 26th ed. Wayne, PA: Clinical and Laboratory Standars Institute; 2016
    [Google Scholar]
  18. Stamm W, Grayson ML, Nicolle L, Powell M. WHO Global Strategy for Containment of Antimicrobial Resistance (Document No: WHO/CDS/CSR/DRS/2001.2) Geneva: World Health Organization; 2001
    [Google Scholar]
  19. Christensen GD, Simpson WA, Younger JJ, Baddour LM, Barrett FF et al. Adherence of coagulase-negative staphylococci to plastic tissue culture plates: a quantitative model for the adherence of staphylococci to medical devices. J Clin Microbiol 1985;22:996–1006[PubMed]
    [Google Scholar]
  20. Chung M, de Lencastre H, Matthews P, Tomasz A, Adamsson I et al. Molecular typing of methicillin-resistant Staphylococcus aureus by pulsed-field gel electrophoresis: comparison of results obtained in a multilaboratory effort using identical protocols and MRSA strains. Microb Drug Resist 2000;6:189–198 [CrossRef][PubMed]
    [Google Scholar]
  21. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE et al. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995;33:2233–2239[PubMed]
    [Google Scholar]
  22. Jarraud S, Mougel C, Thioulouse J, Lina G, Meugnier H et al. Relationships between Staphylococcus aureus genetic background, virulence factors, agr groups (alleles), and human disease. Infect Immun 2002;70:631–641 [CrossRef][PubMed]
    [Google Scholar]
  23. Enright MC, Day NP, Davies CE, Peacock SJ, Spratt BG. Multilocus sequence typing for characterization of methicillin-resistant and methicillin-susceptible clones of Staphylococcus aureus. J Clin Microbiol 2000;38:1008–1015[PubMed]
    [Google Scholar]
  24. Muro S, Garza-González E, Camacho-Ortiz A, González GM, Llaca-Díaz JM et al. Risk factors associated with extended-spectrum β-lactamase-producing Enterobacteriaceae nosocomial bloodstream infections in a tertiary care hospital: a clinical and molecular analysis. Chemotherapy 2012;58:217–224 [CrossRef][PubMed]
    [Google Scholar]
  25. Bhattacharya S, Bir R, Majumdar T. Evaluation of multidrug resistant Staphylococcus aureus and their association with biofilm production in a Tertiary Care Hospital, Tripura, Northeast India. J Clin Diagn Res 2015;9:DC01–04 [CrossRef][PubMed]
    [Google Scholar]
  26. Zhou YP, Wilder-Smith A, Hsu LY. The role of international travel in the spread of methicillin-resistant Staphylococcus aureus. J Travel Med 2014;21:272–281 [CrossRef][PubMed]
    [Google Scholar]
  27. Velazquez-Meza ME, Ayala-Gaytán J, Carnalla-Barajas MN, Soto-Noguerón A, Guajardo-Lara CE et al. First report of community-associated methicillin-resistant Staphylococcus aureus (USA300) in Mexico. J Clin Microbiol 2011;49:3099–3100 [CrossRef][PubMed]
    [Google Scholar]
  28. Win MK, Soliman TA, Lee LK, Wong CS, Chow A et al. Review of a two-year methicillin-resistant Staphylococcus aureus screening program and cost-effectiveness analysis in Singapore. BMC Infect Dis 2015;15:391 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000487
Loading
/content/journal/jmm/10.1099/jmm.0.000487
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error